Skip to main content
Premium Trial:

Request an Annual Quote

Zach Pitluk

Premium

Gene Network Sciences this week said that Zach Pitluk has joined the company as vice president of business development.

Pitluk joins GNS from German informatics firm Definiens, where he served as the North America life sciences business manager. Pitluk previously spent five years at Fisher Biosciences business unit Cellomics. Prior to this, he held sales positions at Clontech Labs, Bristol-Myers Squibb, and ISCO.

Pitluk holds a PhD in molecular biophysics and biochemistry from Yale University.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.